Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

力文 - NMPA Drug Approval Details

Approvals/NMPA/Structural Fat Emulsion Injection (C6~24)

Approved

化学药品

Structural Fat Emulsion Injection (C6~24)

Fresenius Kabi AB🇨🇳 National Medical Products Administration

Approval Date: Apr 10, 2020
Approval ID: 7MazXc2cHOF
Company: Fresenius Kabi AB
Type: 化学药品

Approval Details

Approval Id: 7MazXc2cHOF
Approval Number: H20160018
Generic Name: 结构脂肪乳注射液(C6~24)
Generic Name En: Structural Fat Emulsion Injection (C6~24)
Trade Name: 力文
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 250ml:结构甘油三酯50g
Reg Date: 2020-04-10
Expired Date: 2025-04-09
Company Name: Fresenius Kabi AB
Company Address: SE-751 74 Uppsala,Sweden
Production Company Name: Fresenius Kabi AB
Production Company Address: SE-751 74 Uppsala,Sweden
Company Detail Path: /organization/fresenius-kabi-ab
Production Company Detail Path: /organization/fresenius-kabi-ab

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 10, 2020

Approval ID

7MazXc2cHOF

Type

化学药品

Back to NMPA Approvals